STEMCELL Technologies, Inc. Follow / Connect - Business Profile & Social Media Wall / Press Room - Pharma / BioTech / Nutrition

STEMCELL Technologies, Inc. Company Profile & Social Media Wall Press Room - Press Releases

STEMCELL Technologies, Inc. is a leader in the development and marketing of specialty cell culture media, cell separation products and ancillary reagents for life science research.

	Company Name:	STEMCELL Technologies, Inc.
	Trading Symbol(s):	[]
	Contact:	Press Office - Stemcell.com
	Address:	Confidential
	City:	Vancouver
	Zip code:	V5Z1B3
	STATE / Prov.:	British Columbia
	Country:	Canada
	Primary Industry:	Pharma / BioTech / Nutrition
	PR Agency:	No

Your Company Advertising Here!
Showing along with this industry
- Learn more...

Latest Articles:
Genome BC, STEMCELL Technologies and UBC Partner to Accelerate the Ability to Develop Stem Cells - [ Pharma / BioTech / Nutrition ]
STEMCELL Technologies and Axion BioSystems Partner to Streamline Culture and Analysis of Excitable Cells - [ Pharma / BioTech / Nutrition ]
STEMCELL Technologies Announces FDA De Novo Classification for Its EasySep™ CD138 Positive Selection Kit to Support Cancer Diagnostic Tests - [ Pharma / BioTech / Nutrition ]
STEMCELL Technologies Announces Successful Asset Purchase Agreement with SQZ Biotechnologies Company - [ Pharma / BioTech / Nutrition ]
STEMCELL Technologies Wins a Canada’s Most Admired Corporate Cultures™ of 2023 Award - [ Pharma / BioTech / Nutrition ]
STEMCELL Technologies Launches Human Pluripotent Stem Cell Characterization and Banking Services in Partnership with WiCell - [ Pharma / BioTech / Nutrition ]
STEMCELL Technologies and Hubrecht Organoid Technology to Partner on Non-Oncology Organoid Drug Screening Services - [ Pharma / BioTech / Nutrition ]
STEMCELL Technologies Wins Deloitte Best Managed Companies Award - [ Pharma / BioTech / Nutrition ]
STEMCELL Technologies Launches mTeSR™ Plus - A Next-Generation Culture System for Human ES and iPS Cell Maintenance - [ Pharma / BioTech / Nutrition ]
STEMCELL Technologies Signs Exclusive License to Commercialize Human Pluripotent Stem Cell-Derived Kidney Organoid Culture System - [ Pharma / BioTech / Nutrition ]
STEMCELL Technologies Signs Exclusive Agreement with the Institute of Molecular Biotechnology to Commercialize Cerebral Organoid Culture Systems - [ Pharma / BioTech / Nutrition ]
STEMCELL Technologies Launches Innovative Products to Support CAR T Cell Research - [ Pharma / BioTech / Nutrition ]
STEMCELL Technologies Named Company of the Year by BIOTECanada - [ Pharma / BioTech / Nutrition ]
STEMCELL Technologies to Commercialize BrainPhys™ Neuronal Culture Medium for Improved Support of Neurophysiological Activity - [ Pharma / BioTech / Nutrition ]
STEMCELL Technologies, Inc. Released New MesenCult™ Proliferation Kit with MesenPure™ - [ Pharma / BioTech / Nutrition ]
The HUB Foundation for Organoid Technology and STEMCELL Technologies Sign Agreement on the Manufacturing of Cell Culture Media for Organoids - [ Pharma / BioTech / Nutrition ]
STEMCELL Technologies Receives Government of Canada Support to Develop New Cell Isolation Technology - [ Pharma / BioTech / Nutrition ]
STEMCELL Technologies Publishes Critical Points for Feeder-independent Cultures in mTeSR™1 or TeSR™2 - [ Pharma / BioTech / Nutrition ]
STEMCELL Technologies, Inc. Introduces New Products for Automated and Standardized Counting of Hematopoietic Progenitors - [ Pharma / BioTech / Nutrition ]
STEMCELL Technologies, Inc. Announces StemSpan™ ACF, The First Plasma Component-free Hematopoietic Expansion Media - [ Pharma / BioTech / Nutrition ]
STEMCELL Technologies, Inc. to Launch TeSR-E8 - A New Product to Advance Research on Human Pluripotent Stem Cells - [ Pharma / BioTech / Nutrition ]
New PneumaCult™-ALI Medium for Air-Liquid Interface Culture of Bronchial Epithelial Cells - [ Pharma / BioTech / Nutrition ]

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business

ó See your Ad Here! ó

PREMIUM Members

ó See your Logo Here! ó